SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-022595
Filing Date
2022-11-07
Accepted
2022-11-07 16:06:50
Documents
13
Period of Report
2022-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20221107.htm   iXBRL 8-K 60500
2 EX-99.1 allk-ex99_1.htm EX-99.1 246736
  Complete submission text file 0000950170-22-022595.txt   436180

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20221107_pre.xml EX-101.PRE 9898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20221107_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20221107.xsd EX-101.SCH 2466
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-20221107_htm.xml XML 4741
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 221365432
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences